Relationrx
Director, Antibody Discovery
London · posted 2026-11-17 · listed from another job board
Source: Arbeitnow — view original listing and apply. No platform account required.
At a glance
- Workplace
- Onsite
- Location
- London
- Region
- Europe
- Time zones
- UTC
- Employment type
- Full time
- Seniority
- Director
- Skills
- AI
- Posted
- 2026-11-17
About the job
About Relation
Relation is a sector defining TechBio company developing transformational medicines, with technology at our core. Our ambition is to understand human biology in unprecedented ways, discovering therapies to treat some of life’s most devastating diseases. We leverage single-cell multi-omics from patient tissue, functional assays, and machine learning to drive disease understanding, from cause to cure.
We are scaling rapidly and building a team of exceptional individuals to push the boundaries of drug discovery. You will work in highly interdisciplinary teams where biology, computation, and engineering come together to solve complex problems that have not been solved before. Our state-of-the-art wet and dry labs in the heart of London are designed to accelerate this integration and translate insight into impact.
We are committed to building diverse and inclusive teams. Relation is an equal opportunities employer and does not discriminate on the basis of gender, sexual orientation, marital or civil partnership status, gender reassignment, race, colour, nationality, ethnic or national origin, religion or belief, disability, or age.
By joining Relation, you will help define how medicines are discovered and deliver meaningful impact for patients.
The opportunity
Relation is offering an outstanding opportunity for a Director, Antibody Discovery to lead our antibody discovery function and help drive our growing biologics portfolio. This role will turn Relation’s patient-derived understanding of disease biology into differentiated antibody therapeutics, accelerating the journey from novel target to development candidate.
As functional lead, you will lead a small, high-performing team of antibody scientists and drive the strategic build of Relation’s antibody capabilities — combining in-house platforms, computational and machine learning-enabled design, external partnerships and a carefully managed network of CROs to deliver high-quality molecules efficiently. Alongside this leadership remit, the role is deliberately hands-on: you will serve as the design lead on one or more drug discovery programmes, owning the molecular design strategy from project initiation, through hit identification and lead optimisation, to the nomination of a development candidate.
Sitting within Relation’s Drug Discovery team, this position is deeply embedded within cross-functional matrix project teams and will support multiple disease areas as our portfolio grows. You will work closely with Target Biology, Machine Learning, Protein Sciences, in vivo Pharmacology, Translational Safety, DMPK and CMC to ensure that every molecule is designed with efficacy, safety, developability and manufacturability in mind. As the portfolio develops, you may also take accountability as Project Leader, leading a cross-functional team of scientists and owning the overall project strategy and delivery to development candidate.
Your scope will span the full breadth of antibody formats, from monoclonal antibodies to bispecific and multi-specific molecules, antibody-drug conjugates and other engineered biologics.
The role is a hybrid role based at our state-of-the-art facility in the heart of London.
Day to day, you will
Build and lead Relation’s antibody design function, recruiting, mentoring and developing a small team of antibody scientists, setting standards for scientific excellence and championing innovative approaches to drive data-informed decisions.
Define and execute the strategy for building Relation’s antibody discovery capabilities, determining the right balance of in-house, partnered and outsourced activity, and evaluating and onboarding new technologies such as in vivo immunisation (including transgenic platforms), display libraries, single B-cell screening and computational / AI-enabled de novo design.
Act as the hands-on antibody design lead on one or more drug discovery programmes, translating target biology and the target product profile into a molecular design strategy — including format, epitope, affinity, valency, mechanism of action and Fc engineering — from project initiation to development candidate.
Prosecute antibody discovery campaigns end-to-end: antigen and reagent strategy, hit generation, hit triage and screening cascades, and lead optimisation through affinity maturation, humanisation, specificity profiling and cross-reactivity to toxicology species, culminating in candidate selection.
Embed developability and manufacturability from the outset, using in silico and experimental assessment of sequence liabilities, biophysical properties, stability, expression and immunogenicity risk, and partnering with CMC to de-risk the path to the clinic.
Integrate computational, structural and machine learning-enabled design into iterative design–make–test–learn cycles.
Establish and manage CRO and external partner relationships, leading partner selection, scoping and contracting, and providing scientific oversig…